Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit
FDA 510(k) clearance K233453 · decided 2024-07-10
Clearance details
- K-number
- K233453
- Device name
- Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit
- Applicant
- Life Technologies Corporation
- Decision
- Substantially Equivalent
- Date received
- 2023-10-20
- Decision date
- 2024-07-10
- Days to decision
- 264 days
- Clearance type
- Traditional
- Product code
- QQX
- Device class
- 2
- Regulation number
- 866.3981
- Medical specialty
- Microbiology
- Advisory committee
- Microbiology
- Location
- Pleasanton,, CA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Life Technologies Corporation
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| Aptima SARS-CoV-2 Assay (K243396) | Hologic, Inc. | 2025-02-13 |
| cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems (K240867) | Roche Molecular Systems, Inc. | 2025-02-11 |
| Xpert® Xpress CoV-2 plus (XPRS-COV2-10) (K242109) | Cepheid® | 2025-01-15 |
| Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086) (K241580) | Abbott Molecular | 2024-12-06 |
| Xpert® Xpress CoV-2 plus (K230440) | Cepheid® | 2023-10-13 |
| cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems (K231306) | Roche Molecular Systems, Inc. | 2023-06-01 |
| cobas SARS-CoV-2 Qualitative for use on the cobas 6800/8800 Systems (K213804) | Roche Molecular Systems, Inc. | 2022-10-22 |
| Simplexa COVID-19 Direct (K212147) | Diasorin Molecular, LLC | 2022-09-13 |
| BioFire COVID-19 Test 2 (K221460) | Biofire Defense, LLC | 2022-07-25 |
| BioFire COVID-19 Test 2 (K211079) | Biofire Defense, LLC | 2021-11-01 |
Recalls involving this device
No recalls on record reference this clearance.
PMA approvals by this applicant
| Record | Firm | Date |
|---|---|---|
| Oncomine Dx Target Test (P160045/S051) | Life Technologies Corporation | 2025-11-21 |
| Oncomine Dx Target Test (P160045/S050) | Life Technologies Corporation | 2025-11-19 |
| Oncomine Dx Express Test (P240040/S003) | Life Technologies Corporation | 2025-10-22 |
| Oncomine Dx Express Test (P240040/S002) | Life Technologies Corporation | 2025-10-15 |
| Oncomine Dx Target Test (P160045/S049) | Life Technologies Corporation | 2025-08-08 |
| Oncomine Dx Express Test (P240040/S001) | Life Technologies Corporation | 2025-08-07 |
| Oncomine Dx Express Test (P240040) | Life Technologies Corporation | 2025-07-02 |
| Oncomine Dx Target Test (P160045/S046) | Life Technologies Corporation | 2024-10-17 |